Fluticasone Propionate/Formoterol Fumarate

DRUG4 trials

Sponsors

SkyePharma AG, Dey

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 2

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT00403286

DeyChronic Obstructive Pulmonary Disease

Start: 2006-11-30End: 2007-05-31Updated: 2009-06-30

A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT00774761

DeyChronic Obstructive Pulmonary Disease

Start: 2008-11-30End: 2009-05-31Updated: 2013-05-20

A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT01168310

DeyChronic Obstructive Pulmonary Disease

Start: 2010-08-31End: 2011-10-31Updated: 2013-05-27

Phase 3

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma

CompletedNCT00394121

SkyePharma AGAsthma

Start: 2006-03-31End: 2007-07-31Target: 400Updated: 2010-08-27